{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:39:42Z","timestamp":1790739582745,"version":"4.1.0"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T00:00:00Z","timestamp":1388620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jsps.2013.12.019","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T13:17:14Z","timestamp":1388755034000},"page":"587-602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Systemic delivery of \u03b2-blockers via transdermal route for hypertension"],"prefix":"10.1007","volume":"23","author":[{"given":"Abdul","family":"Ahad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad I.","family":"Al-Jenoobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah M.","family":"Al-Mohizea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naseem","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Raish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd.","family":"Aqil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.jsps.2013.12.019_b0005","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cct.2010.03.013","article-title":"Randomised, cross-over, comparative bioavailability trial of matrix type transdermal drug delivery system (TDDS) of carvedilol and hydrochlorothiazide combination in healthy human volunteers: a pilot study","volume":"31","author":"Agrawal","year":"2010","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.jsps.2013.12.019_b0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4103\/0250-474X.36940","article-title":"Permeation studies of atenolol and metoprolol tartrate from three different polymer matrices for transdermal delivery","volume":"69","author":"Agrawal","year":"2007","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.jsps.2013.12.019_b0015","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1517\/17425247.2013.783562","article-title":"Transdermal delivery of calcium channel blockers for hypertension","volume":"10","author":"Ahad","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jsps.2013.12.019_b9000","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijbiomac.2013.11.018","article-title":"Investigation of antihypertensive activity of carbopol valsartan transdermal gel containing 1,8-cineole","volume":"64","author":"Ahad","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jsps.2013.12.019_b0020","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1517\/13543770902989983","article-title":"Chemical penetration enhancers: a patent review","volume":"19","author":"Ahad","year":"2009","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.jsps.2013.12.019_b0025","first-page":"276","article-title":"Transdermal drug delivery: the inherent challenges and technological advancements","volume":"5","author":"Ahad","year":"2010","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.jsps.2013.12.019_b0030","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/156720111794479907","article-title":"Interactions between novel terpenes and main components of rat and human skin: mechanistic view for transdermal delivery of propranolol hydrochloride","volume":"8","author":"Ahad","year":"2011","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jsps.2013.12.019_b0035","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nano.2011.06.004","article-title":"Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan","volume":"8","author":"Ahad","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jsps.2013.12.019_b0040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijpharm.2013.01.011","article-title":"Enhanced transdermal delivery of an anti-hypertensive agent via nanoethosomes: statistical optimization, characterization and pharmacokinetic assessment","volume":"443","author":"Ahad","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jsps.2013.12.019_b0045","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1517\/13543776.2011.561784","article-title":"The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review","volume":"21","author":"Akhtar","year":"2011","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.jsps.2013.12.019_b0050","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.amjhyper.2007.02.002","article-title":"Hypertension control: improved, but not enough!","volume":"20","author":"Alderman","year":"2007","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.jsps.2013.12.019_b0055","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/10837450802309646","article-title":"Mechanism of in vitro percutaneous absorption enhancement of carvedilol by penetration enhancers","volume":"13","author":"Amin","year":"2008","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jsps.2013.12.019_b0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2004.11.007","article-title":"Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use","volume":"289","author":"Amnuaikit","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jsps.2013.12.019_b0065","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2340\/0001555571389393","article-title":"Ethanol absorption across human skin measured by in vivo microdialysis technique","volume":"71","author":"Anderson","year":"1991","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.jsps.2013.12.019_b0070","first-page":"155","article-title":"Preparation, in-vitro and in-vivo characterization of transdermal patch containing glibenclamide and atenolol: a combinational approach","volume":"24","author":"Anitha","year":"2011","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.jsps.2013.12.019_b0075","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.drudis.2007.09.001","article-title":"Status of terpenes as skin penetration enhancers","volume":"12","author":"Aqil","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jsps.2013.12.019_b0080","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2165\/00044011-200727120-00005","article-title":"Comparative bioavailability of metoprolol tartrate after oral and transdermal administration in healthy male volunteers","volume":"27","author":"Aqil","year":"2007","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.jsps.2013.12.019_b0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/10717540490265225","article-title":"Transdermal drug delivery systems of a beta blocker: design, in vitro, and in vivo characterization","volume":"11","author":"Aqil","year":"2004","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jsps.2013.12.019_b0090","first-page":"119","article-title":"Matrix type transdermal drug delivery systems of metoprolol tartrate: in vitro characterization","volume":"53","author":"Aqil","year":"2003","journal-title":"Acta Pharm."},{"key":"10.1016\/j.jsps.2013.12.019_b0095","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1517\/17425247.3.3.405","article-title":"Transdermal delivery of beta-blockers","volume":"3","author":"Aqil","year":"2006","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jsps.2013.12.019_b0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/1567201053586038","article-title":"Transdermal drug delivery of labetolol hydrochloride: system development, in vitro; ex vivo and in vivo characterization","volume":"2","author":"Aqil","year":"2005","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jsps.2013.12.019_b0105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2003.11.004","article-title":"Effect of cyclodextrins on the complexation and transdermal delivery of bupranolol through rat skin","volume":"271","author":"Babu","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jsps.2013.12.019_b0110","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijpharm.2004.10.008","article-title":"Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems","volume":"288","author":"Babu","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jsps.2013.12.019_b0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/10717540590931936","article-title":"Effect of penetration enhancers on the transdermal delivery of bupranolol through rat skin","volume":"12","author":"Babu","year":"2005","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jsps.2013.12.019_b0120","first-page":"205","article-title":"Design and evaluation of transdermal drug delivery system of atenolol as an anti-hypertensive drug","author":"Baria","year":"2011","journal-title":"Inventi. Rapid Pharm. Tech."},{"key":"10.1016\/j.jsps.2013.12.019_b0125","first-page":"130","article-title":"Development and characterization of transdermal patches of metoprolol tartrate","volume":"3","author":"Bharkatiya","year":"2010","journal-title":"Asian J. Pharm. Clin. Res."},{"key":"10.1016\/j.jsps.2013.12.019_b0130","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jcis.2009.03.047","article-title":"Assessment of solubilization characteristics of different surfactants for carvedilol phosphate as a function of pH","volume":"335","author":"Chakraborty","year":"2009","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jsps.2013.12.019_b0135","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3949\/ccjm.76a.09030","article-title":"Beta-blockers for hypertension: are they going out of style?","volume":"76","author":"Che","year":"2009","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.jsps.2013.12.019_b0140","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijpharm.2004.08.013","article-title":"Enhanced transdermal delivery of atenolol from the ethylene-vinyl acetate matrix","volume":"287","author":"Cho","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jsps.2013.12.019_b0145","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jsps.2013.12.019_b0150","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0828-282X(06)70275-6","article-title":"Worldwide epidemic of hypertension","volume":"22","author":"Chockalingam","year":"2006","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.jsps.2013.12.019_b0155","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/jps.2600790707","article-title":"Bioavailability of propranolol following oral and transdermal administration in rabbits","volume":"79","author":"Corbo","year":"1990","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jsps.2013.12.019_b0160","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/ptj\/75.6.554","article-title":"Iontophoresis: applications in transdermal medication delivery","volume":"75","author":"Costello","year":"1995","journal-title":"Phys. Ther."},{"key":"10.1016\/j.jsps.2013.12.019_b0165","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s12272-011-0909-2","article-title":"Enhancement and mechanism of transdermal absorption of terpene-induced propranolol hydrochloride","volume":"34","author":"Cui","year":"2011","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.jsps.2013.12.019_b0170","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0168-3659(03)00010-5","article-title":"Transdermal delivery of timolol by electroporation through human skin","volume":"88","author":"Denet","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jsps.2013.12.019_b0175","first-page":"388","article-title":"Development and evaluation of propranolol hydrochloride transdermal patches by using hydrophilic and hydrophobic polymer","volume":"41","author":"Dey","year":"2007","journal-title":"Ind. J. Pharm. Educ. Res."},{"key":"10.1016\/j.jsps.2013.12.019_b0180","first-page":"1955","article-title":"Formulation and evaluation of bisoprolol fumarate transdermal patches","volume":"3","author":"Dinakar","year":"2010","journal-title":"J. Pharm. Res."},{"key":"10.1016\/j.jsps.2013.12.019_b0185","first-page":"46","article-title":"Nanoemulsion system for the transdermal delivery of a poorly soluble cardiovascular drug","volume":"62","author":"Dixit","year":"2008","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"10.1016\/j.jsps.2013.12.019_b0190","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejpb.2008.12.003","article-title":"Novel transdermal delivery of timolol maleate using sugar esters: preclinical and clinical studies","volume":"72","author":"El-Laithy","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jsps.2013.12.019_b0195","first-page":"391","article-title":"Development of carvedilol transdermal patches: evaluation of physicochemical, ex vivo and mechanical properties","volume":"62","author":"Gannu","year":"2008","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"10.1016\/j.jsps.2013.12.019_b0200","first-page":"256","article-title":"In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers","volume":"62","author":"Gannu","year":"2008","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"10.1016\/j.jsps.2013.12.019_b0205","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0378-5173(92)90337-2","article-title":"Transdermal delivery of metoprolol. I. Comparison between hairless mouse and human cadaver skin and effect of N-decylmethyl sulfoxide","volume":"88","author":"Ghosh","year":"1992","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jsps.2013.12.019_b0210","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1751-7176.2009.00179.x","article-title":"Definition and classification of hypertension: an update","volume":"11","author":"Giles","year":"2009","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.jsps.2013.12.019_b0215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0168-3659(96)01354-5","article-title":"Iontophoretic delivery of peptide drugs","volume":"41","author":"Green","year":"1996","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jsps.2013.12.019_b0220","first-page":"1","article-title":"Cutaneous microdialysis. Methodology and validation","volume":"197","author":"Groth","year":"1996","journal-title":"Acta Derm. Venereol. Suppl. (Stockh)"},{"issue":"9","key":"10.1016\/j.jsps.2013.12.019_b0225","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.4155\/tde.12.87","article-title":"Systemic delivery of antihypertensive drugs via skin","volume":"3","author":"G\u00fcng\u00f6r","year":"2012","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jsps.2013.12.019_b0230","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0378-5173(00)00494-4","article-title":"Design and in vitro evaluation of adhesive matrix for transdermal delivery of propranolol","volume":"204","author":"Guyot","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jsps.2013.12.019_b0235","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1517\/17425240903338758","article-title":"Chemical permeation enhancers for transbuccal drug delivery","volume":"7","author":"Hassan","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jsps.2013.12.019_b0240","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0378-4347(99)00248-0","article-title":"Rapid and simple micro-determination of carvedilol in rat plasma by high-performance liquid chromatography","volume":"732","author":"Hokama","year":"1999","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jsps.2013.12.019_b0245","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/jps.2600810406","article-title":"Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro. II. Drug, vehicle, and enhancer penetration kinetics","volume":"81","author":"Hori","year":"1992","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jsps.2013.12.019_b0250","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jps.2600800109","article-title":"Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro: effect of enhancer lipophilicity","volume":"80","author":"Hori","year":"1991","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jsps.2013.12.019_b0255","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/03639040701657958","article-title":"Basil oil is a promising skin penetration enhancer for transdermal delivery of labetolol hydrochloride","volume":"34","author":"Jain","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jsps.2013.12.019_b0260","first-page":"379","article-title":"Development of transdermal matrix system of captopril based on cellulose derivative","volume":"1","author":"Jain","year":"2007","journal-title":"Pharmacolgyonline"},{"key":"10.1016\/j.jsps.2013.12.019_b0265","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0378-5173(99)00457-3","article-title":"Transdermal iontophoretic delivery of timolol maleate in albino rabbits","volume":"197","author":"Kanikkannan","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jsps.2013.12.019_b0270","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0168-3659(01)00208-5","article-title":"In vitro transdermal iontophoretic transport of timolol maleate: effect of age and species","volume":"71","author":"Kanikkannan","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jsps.2013.12.019_b0275","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(05)70151-3","article-title":"Global burden of hypertension: analysis of worldwide data","volume":"365","author":"Kearney","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jsps.2013.12.019_b0280","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijpharm.2003.12.004","article-title":"Controlled release of atenolol from the ethylene-vinyl acetate matrix","volume":"273","author":"Kim","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jsps.2013.12.019_b0285","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.3109\/03639045.2012.656271","article-title":"Development and evaluation of carvedilol-loaded transdermal drug delivery system: in-vitro and in-vivo characterization study","volume":"38","author":"Kshirsagar","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jsps.2013.12.019_b0290","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2125.1991.tb05564.x","article-title":"Skin irritation induced by topically applied timolol","volume":"31","author":"Kubota","year":"1991","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jsps.2013.12.019_b0295","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1021\/js970161+","article-title":"Effect of menthol and related terpenes on the percutaneous absorption of propranolol across excised hairless mouse skin","volume":"86","author":"Kunta","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jsps.2013.12.019_b0300","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/j.1552-4604.1986.tb02959.x","article-title":"Basic pharmacokinetics of bisoprolol, a new highly beta 1-selective adrenoceptor antagonist","volume":"26","author":"Leopold","year":"1986","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jsps.2013.12.019_b0305","first-page":"186","article-title":"Recent update in the management of hypertension","volume":"39","author":"Lim","year":"2007","journal-title":"Acta Med. Indones."},{"key":"10.1016\/j.jsps.2013.12.019_b0310","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/j.1875-9114.1983.tb03252.x","article-title":"Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects","volume":"3","author":"MacCarthy","year":"1983","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jsps.2013.12.019_b0315","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0168-3659(95)00063-E","article-title":"In vivo characterization of transdermal drug transport by microdialysis","volume":"37","author":"Muller","year":"1995","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jsps.2013.12.019_b0320","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jps.20737","article-title":"Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride","volume":"96","author":"Mishra","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jsps.2013.12.019_b0325","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2174\/156720109789941614","article-title":"In vitro and in vivo assessment of matrix type transdermal therapeutic system of labetalol hydrochloride","volume":"6","author":"Mittal","year":"2009","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jsps.2013.12.019_b0330","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/00003088-199426050-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of carvedilol","volume":"26","author":"Morgan","year":"1994","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jsps.2013.12.019_b0335","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/S0895-7061(97)00016-2","article-title":"Evolution of the treatment of hypertension from the 1940s to JNC V","volume":"10","author":"Moser","year":"1997","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.jsps.2013.12.019_b0340","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/03639040600897127","article-title":"Development of polysaccharide-based colon targeted drug delivery systems for the treatment of amoebiasis","volume":"33","author":"Mundargi","year":"2007","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jsps.2013.12.019_b0345","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/03639040600975030","article-title":"Evaluation and controlled release characteristics of modified xanthan films for transdermal delivery of atenolol","volume":"33","author":"Mundargi","year":"2007","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jsps.2013.12.019_b0350","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0168-3659(02)00106-2","article-title":"Liquid crystalline pharmacogel based enhanced transdermal delivery of propranolol hydrochloride","volume":"82","author":"Namdeo","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jsps.2013.12.019_b0355","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/000331977802900410","article-title":"Advantages and disadvantages of beta-adrenergic blocking drugs in hypertension","volume":"29","author":"O\u2019Brien","year":"1978","journal-title":"Angiology"},{"key":"10.1016\/j.jsps.2013.12.019_b0360","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1248\/bpb.24.588","article-title":"Transdermal absorption of bupranolol in rabbit skin in vitro and in vivo","volume":"24","author":"Ogiso","year":"2001","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jsps.2013.12.019_b0365","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0169-409X(98)00063-5","article-title":"Practical assessment of transdermal drug delivery by skin electroporation","volume":"3","author":"Prausnitz","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jsps.2013.12.019_b0370","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1081\/PDT-100102030","article-title":"Drug release kinetics from polymeric films containing propranolol hydrochloride for transdermal use","volume":"5","author":"Rao","year":"2000","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jsps.2013.12.019_b0375","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0939-6411(03)00038-9","article-title":"Comparative in vivo evaluation of propranolol hydrochloride after oral and transdermal administration in rabbits","volume":"56","author":"Rao","year":"2003","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jsps.2013.12.019_b0380","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/17458080903583964","article-title":"Enhanced transdermal delivery of carvedilol using nanoemulsion as a vehicle","volume":"5","author":"Rizwan","year":"2010","journal-title":"J. Exp. Nanosci."},{"key":"10.1016\/j.jsps.2013.12.019_b0385","series-title":"Iontophoresis, Encyclopedia of Pharmaceutical Technology","author":"Sage","year":"1993"},{"key":"10.1016\/j.jsps.2013.12.019_b0390","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1681\/ASN.2005121329","article-title":"Thiazide diuretics in the treatment of hypertension: an update","volume":"17","author":"Salvetti","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsps.2013.12.019_b0395","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/10717540802327047","article-title":"Transdermal delivery of carvedilol containing glycyrrhizin and chitosan as permeation enhancers: biochemical, biophysical, microscopic and pharmacodynamic evaluation","volume":"15","author":"Sapra","year":"2008","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jsps.2013.12.019_b0400","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1080\/03639040902882272","article-title":"Transdermal delivery of carvedilol in rats: probing the percutaneous permeation enhancement mechanism of soybean extract-chitosan mixture","volume":"35","author":"Sapra","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jsps.2013.12.019_b0405","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1208\/s12249-009-9198-1","article-title":"Effect of Asparagus racemosus extract on transdermal delivery of carvedilol: a mechanistic study","volume":"10","author":"Sapra","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jsps.2013.12.019_b0410","first-page":"1","article-title":"Transdermal drug delivery systems for antihypertensive drugs \u2013 a review","volume":"1","author":"Selvam","year":"2010","journal-title":"Int. J. Pharm. Biomed. Res."},{"key":"10.1016\/j.jsps.2013.12.019_b0415","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0939-6411(03)00133-4","article-title":"Enhanced bioavailability of atenolol by transdermal administration of the ethylene-vinyl acetate matrix in rabbits","volume":"56","author":"Shin","year":"2003","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jsps.2013.12.019_b0420","doi-asserted-by":"crossref","DOI":"10.1208\/pt070103","article-title":"Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology","volume":"7","author":"Singh","year":"2006","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jsps.2013.12.019_b0425","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.colsurfb.2012.07.017","article-title":"Optimized nanoemulsifying systems with enhanced bioavailability of carvedilol","volume":"101","author":"Singh","year":"2013","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.jsps.2013.12.019_b0430","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/med.2610130504","article-title":"Transdermal drug delivery by passive diffusion and iontophoresis: a review","volume":"13","author":"Singh","year":"1993","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jsps.2013.12.019_b0435","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1208\/s12249-012-9808-1","article-title":"The control of skin-permeating rate of bisoprolol by ion-pair strategy for long-acting transdermal patches","volume":"13","author":"Song","year":"2012","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jsps.2013.12.019_b0440","first-page":"73","article-title":"Comparison between the iontophoretic and passive transdermal delivery of timolol maleate across human cadaver skin","volume":"49","author":"Soni","year":"1994","journal-title":"Pharmazie"},{"key":"10.1016\/j.jsps.2013.12.019_b0445","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0168-3659(99)00214-X","article-title":"Intradermal microdialysis: kinetics of iontophoretically delivered propranolol in forearm dermis","volume":"63","author":"Stagni","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jsps.2013.12.019_b0450","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/chir.530050104","article-title":"Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic and radioligard binding studies","volume":"5","author":"Stoschitzky","year":"1993","journal-title":"Chirality"},{"key":"10.1016\/j.jsps.2013.12.019_b0455","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jconrel.2008.05.001","article-title":"Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane","volume":"129","author":"Suedee","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jsps.2013.12.019_b0460","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0378-5173(89)90303-7","article-title":"Diffusion kinetics of alkyl p-aminobenzoates in silicone polymers and their release from silicone reservoir devices","volume":"57","author":"Sutinen","year":"1989","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jsps.2013.12.019_b0465","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0928-0987(00)00083-X","article-title":"Water-activated, pH-controlled patch in transdermal administration of timolol. II. Drug absorption and skin irritation","volume":"11","author":"Sutinen","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jsps.2013.12.019_b0470","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0928-0987(00)00082-8","article-title":"Water-activated, pH-controlled patch in transdermal administration of timolol. I. Preclinical tests","volume":"11","author":"Sutinen","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jsps.2013.12.019_b0475","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0378-5173(90)90224-R","article-title":"Water-activated and pH-controlled release of weak bases from silicone reservoir devices","volume":"62","author":"Sutinen","year":"1990","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jsps.2013.12.019_b0480","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0142-9612(95)98278-M","article-title":"Development and in vitro evaluation of chitosan-based transdermal drug delivery systems for the controlled delivery of propranolol hydrochloride","volume":"16","author":"Thacharodi","year":"1995","journal-title":"Biomaterials"},{"key":"10.1016\/j.jsps.2013.12.019_b0485","first-page":"443","article-title":"Formulation, development and characterization of transdermal film of metoprolol succinate using hydrophilic and hydrophobic polymer","author":"Thakare","year":"2012","journal-title":"Inventi. Rapid NDDS"},{"key":"10.1016\/j.jsps.2013.12.019_b0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(02)00004-4","article-title":"Oleic acid, a skin penetration enhancer, affects langerhans cells and corneocytes","volume":"80","author":"Touitou","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jsps.2013.12.019_b0495","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000265407","article-title":"Bupranolol, a beta 1- and beta 2-blocker, causes constriction of the pupil in men","volume":"18","author":"Tsukahara","year":"1986","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.jsps.2013.12.019_b0500","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1208\/pt0801002","article-title":"Transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics","volume":"8","author":"Ubaidulla","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jsps.2013.12.019_b0505","first-page":"66","article-title":"Long-term stability characterization of a controlled release gastrointestinal therapeutic system coated with a cellulose acetate pseudolatex","volume":"56","author":"Vaithiyalingam","year":"2001","journal-title":"Pharmazie"},{"key":"10.1016\/j.jsps.2013.12.019_b0510","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1023\/A:1016093920875","article-title":"Transdermal delivery of fentanyl by electroporation. I. Influence of electrical factors","volume":"13","author":"Vanbever","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jsps.2013.12.019_b0515","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1023\/A:1018930425591","article-title":"Transdermal delivery of metoprolol by electroporation","volume":"11","author":"Vanbever","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jsps.2013.12.019_b0520","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1081\/DDC-100101257","article-title":"Transdermal delivery of propranolol using mixed grades of Eudragit: design and in vitro and in vivo evaluation","volume":"26","author":"Verma","year":"2000","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jsps.2013.12.019_b0525","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0090-9556(25)07835-3","article-title":"Metabolic fate of the \u03b2-blocker 14C-bupranolol in humans, dogs, and rhesus monkeys","volume":"10","author":"Waller","year":"1982","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jsps.2013.12.019_b0530","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF00613517","article-title":"Transdermal delivery of bupranolol: pharmacodynamics and beta-adrenoceptor occupancy","volume":"31","author":"Wellstein","year":"1986","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jsps.2013.12.019_b0535","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopha.2010.01.012","article-title":"Carvedilol ameliorates sympathetic nerve sprouting and electrical remodeling after myocardial infarction in rats","volume":"64","author":"Wen","year":"2010","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jsps.2013.12.019_b0540","article-title":"Animal models for transdermal delivery","volume":"vol. I","author":"Wester","year":"1987"},{"key":"10.1016\/j.jsps.2013.12.019_b0545","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.addr.2003.10.025","article-title":"Penetration enhancers","volume":"56","author":"Williams","year":"2004","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.jsps.2013.12.019_b0550","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4103\/0975-7406.72132","article-title":"Transdermal drug delivery of labetalol hydrochloride: feasibility and effect of penetration enhancers","volume":"2","author":"Zafar","year":"2010","journal-title":"J. Pharm. Bioallied Sci."},{"key":"10.1016\/j.jsps.2013.12.019_b0555","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijpharm.2006.12.030","article-title":"A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization","volume":"337","author":"Zhao","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jsps.2013.12.019_b0560","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0168-3659(99)00171-6","article-title":"In vitro percutaneous absorption enhancement of propranolol hydrochloride through porcine epidermis by terpenes\/ethanol","volume":"62","author":"Zhao","year":"1999","journal-title":"J. Control. Release"}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016413001461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016413001461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T10:48:06Z","timestamp":1746096486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016413001461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":113,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1319016413001461"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2013.12.019","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic delivery of \u03b2-blockers via transdermal route for hypertension","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2013.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Saudi Pharmaceutical Journal. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}